PanMETAI combines AI and NMR metabolomics to detect early-stage pancreatic cancer from a blood sample, achieving 93 percent ...
Explore how proteomics in biomarker discovery accelerates diagnostic assay development and improves clinical validation.
Enterprises seeking to make good on the promise of agentic AI will need a platform for building, wrangling, and monitoring AI agents in purposeful workflows. In this quickly evolving space, myriad ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results